Furthermore, comparative analysis between the T2DM cohort and the T2DM + NAFLD comorbid cohort revealed intensified inflammatory activity in comorbid patients with higher levels of CRP, FER, NLR, and MHR. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.